Medically Reviewed By:
Written By:
Last Modified April 17, 2022
This page features 12 Cited Research Articles
Fact Checked
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed

Asbestos.com is the nation’s most trusted mesothelioma resource

The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.

Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.

More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.

About The Mesothelioma Center at Asbestos.com

  • Assisting mesothelioma patients and their loved ones since 2006.
  • Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed mesothelioma and support organization.
Learn More About Us

Testimonials

"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."
Lashawn
Mesothelioma patient’s daughter
  • Google Review Rating
  • BBB Review Rating
Read Our Testimonials

What is Paclitaxel?

Paclitaxel is approved by the U.S. Food and Drug Administration (FDA) for use against breast cancer, non-small cell lung cancer, ovarian cancer, AIDS-related Kaposi’s sarcoma and pancreatic cancer.

Doctors also use it as an experimental or off-label treatment for bladder cancer, esophageal cancer, melanoma, prostate cancer and mesothelioma. Paclitaxel is commonly given in combination with cisplatin or carboplatin.

A 2021 clinical research study concluded that large doses of intraperitoneal paclitaxel up to 120 mg on a monthly basis or 60 mg on a weekly basis can be combined with cisplatin and other systemic agents with minimal or no additional hematologic toxicity.

Paclitaxel is an antimicrotubule agent. Microtubules are an essential part of the process by which cells divide. Paclitaxel binds to proteins in cell microtubules, which forces cells to stop dividing. Since cancer cells divide rapidly, their microtubules are a good target for chemotherapy.

This drug dates back to the late 1960s, when it was discovered in the bark of the Pacific yew tree. Researchers recognized its potential as an anti-cancer agent, but its natural scarcity made it difficult to market.

More than 20 years later, researchers found a way to produce paclitaxel synthetically. Bristol-Myers Squibb began marketing it as Taxol.

In 2005, the FDA approved a new type of the drug called nanoparticle albumin-bound paclitaxel, or nab-paclitaxel. In this formulation, the drug is contained in tiny particles of protein. This improves drug delivery and reduces side effects. Celgene Corporation markets nab-paclitaxel as Abraxane.

Paclitaxel Information
Name Taxol, Abraxane
Manufacturer Bristol-Myers Squibb, Celgene
Medical Code J9267
Dosage 135 mg/m²
Administration Route Intravenous or intraperitoneal
Active Ingredient Paclitaxel
Drug Class Antineoplastic agent, antimicrotubule agent
Related Drug Docetaxel
Alternate Names Anzatax, Asotax, Bristaxol, Onxol, Praxel
Interacting Drug Adenovirus types 4 and 7 live, antihistamines, apalutamide, eluxadoline, idarubicin, idelalisib, influenza virus vaccine trivalent, ivacaftor, nefazodone, opiates, palifermin, quinidine
Medical Studies Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival
FDA Warning Skin problems, hives, acute allergic reaction characterized by breathing difficulty and low blood pressure
Find a Mesothelioma Cancer Center
Access top mesothelioma cancer centers that have experience treating this rare disease.

Paclitaxel for Pleural Mesothelioma

In the 1990s, studies of paclitaxel (Taxol) as a single agent for pleural mesothelioma showed little effectiveness. Now researchers are testing nab-paclitaxel (Abraxane) in combination with other drugs.

A 2016 study published in Respirology Case Reports described one medical team’s success substituting nab-paclitaxel for pemetrexed.

Standard chemotherapy for mesothelioma combines pemetrexed with cisplatin or carboplatin, but pemetrexed is too toxic for some patients. In the case report, a pleural mesothelioma patient responded well to nab-paclitaxel with carboplatin after standard chemotherapy had failed.

In 2017, Clinical Cancer Research published the results of a laboratory experiment using mesothelioma cells. The researchers combined nab-paclitaxel with an experimental immunotoxin called RG7787, with good results.

That same year, Biomedicine & Pharmacotherapy reported on a novel drug delivery method for mesothelioma. The laboratory experiment involved loading paclitaxel into a special type of cell to help the drug reach cancer cells.

Paclitaxel for Peritoneal Mesothelioma

Paclitaxel also shows promise for peritoneal mesothelioma, according to a 2017 review in the European Journal of Surgical Oncology. The review was co-authored by Dr. Paul Sugarbaker.

Sugarbaker helped pioneer the technique of rinsing a patient’s abdomen with chemotherapy during surgery. This procedure is called hyperthermic intraperitoneal chemotherapy (HIPEC). It is associated with much longer survival times for peritoneal mesothelioma patients.

In the 2017 review, Sugarbaker’s team reported that outcomes are the best for patients who also get long-term paclitaxel. In these follow-up treatments, the drug is delivered to their abdomen to prevent cancer reoccurrence.

Side Effects of Paclitaxel

Like most chemotherapy drugs, paclitaxel damages healthy cells in addition to cancer cells. Side effects are usually worst about 15 to 21 days after treatment.

Common side effects of paclitaxel:

  • Low red- and white-blood-cell counts
  • Hair loss
  • Joint and muscle pain
  • Numbness and tingling in extremities
  • Nausea and vomiting
  • Diarrhea
  • Mouth sores
  • Severe allergic reaction

Rare side effects of paclitaxel:

  • Swelling in feet or ankles
  • Liver problems
  • Low blood pressure
  • Skin darkening at radiation treatment sites
  • Nail discoloration

Mesothelioma packet from the Mesothelioma Center
Get Your Free Mesothelioma Treatment Guide
Laptop with screen video conference on kitchen counter
Watch Our Free Mesothelioma Webinars
Technician documenting notes in a lab
Find Active Mesothelioma Clinical Trials

  •  
  •  
  •  
Tell us what you think
Did this article help you?
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?